Shivaprakash Gangappa Selected Research

Acquired Immunodeficiency Syndrome (AIDS)

4/2012

Influenza A virus neuraminidase protein enhances cell survival through interaction with carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shivaprakash Gangappa Research Topics

Disease

23	Infections 01/2021 - 04/2002
15	Human Influenza (Influenza) 12/2021 - 10/2008
8	Virus Diseases (Viral Diseases) 01/2021 - 11/2002
6	Influenza in Birds (Avian Flu) 11/2018 - 03/2007
3	Inflammation (Inflammations) 01/2021 - 03/2009
2	Communicable Diseases (Infectious Diseases) 01/2017 - 11/2015
2	Persistent Infection 07/2009 - 04/2002
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Chickenpox 01/2021
1	Measles 01/2021
1	COVID-19 12/2020
1	HIV Infections (HIV Infection) 01/2019
1	Meningococcal Meningitis 01/2017
1	Protein-Energy Malnutrition (Marasmus) 01/2017
1	Neoplasms (Cancer) 10/2016
1	Autoimmune Diseases (Autoimmune Disease) 10/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2012
1	Adenocarcinoma of Lung 04/2012
1	Cytokine Release Syndrome 10/2010
1	Ebola Hemorrhagic Fever 09/2009
1	Herpesviridae Infections (Herpesvirus Infection) 04/2002
1	Latent Infection 04/2002

Drug/Important Bio-Agent (IBA)

15	VaccinesIBA 12/2021 - 06/2006
9	Antiviral Agents (Antivirals)IBA 03/2020 - 11/2002
5	Proteins (Proteins, Gene)FDA Link 03/2020 - 04/2002
4	CytokinesIBA 01/2016 - 03/2007
3	EpitopesIBA 01/2021 - 01/2017
3	LigandsIBA 01/2016 - 06/2011
2	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2021 - 01/2019
2	Immunoglobulin G (IgG)IBA 01/2021 - 12/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2016
2	AntibodiesIBA 01/2021 - 12/2020
2	AntigensIBA 01/2021 - 12/2014
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2020 - 06/2011
2	Sirolimus (Rapamycin)FDA Link 10/2016 - 07/2009
2	InterferonsIBA 01/2012 - 04/2002
2	Interleukin-6 (Interleukin 6)IBA 10/2010 - 03/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2010 - 03/2007
1	sialic acid receptorIBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	Superoxides (Superoxide)IBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	ProtollinIBA 01/2017
1	Pharmaceutical PreparationsIBA 10/2016
1	NADPH Oxidase 1IBA 01/2016
1	NADPH Oxidase 2IBA 01/2016
1	EnzymesIBA 01/2016
1	Interleukin-7 (Interleukin 7)IBA 01/2016
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2016
1	InflammasomesIBA 12/2015
1	SodiumIBA 11/2015
1	SaltsIBA 11/2015
1	Neutralizing AntibodiesIBA 11/2015
1	Nuclear Proteins (Protein, Nuclear)IBA 02/2013
1	Viral ProteinsIBA 04/2012
1	Small Interfering RNA (siRNA)IBA 04/2012
1	Neuraminidase (Sialidase)IBA 04/2012
1	5' Untranslated Regions (5' UTR)IBA 01/2012
1	Complement System Proteins (Complement)IBA 01/2012
1	Complementary RNA (cRNA)IBA 01/2012
1	3' Untranslated Regions (3' UTR)IBA 01/2012
1	Chemokine CCL5IBA 04/2011
1	Calcineurin InhibitorsIBA 10/2010
1	CalcineurinIBA 10/2010
1	Tacrolimus (Prograf)FDA LinkGeneric 10/2010
1	Interferon Type IIBA 06/2009
1	Interferon-betaIBA 06/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2009
1	Attenuated VaccinesIBA 04/2008
1	B7-H1 AntigenIBA 09/2007
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2007
1	Interleukin-1 (Interleukin 1)IBA 03/2007
1	Type I Tumor Necrosis Factor ReceptorsIBA 03/2007
1	Chemokine CCL3IBA 03/2007
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 03/2007
1	CyclinsIBA 04/2002

Therapy/Procedure

2	Therapeutics 01/2016 - 09/2009